The Rising Economic Burden of Sleep Disorders in Europe
Nearly one in three Europeans are affected by sleep disorders, resulting in substantial economic consequences. A recent European study published in the European Journal of Neurology highlights the significant financial strain these conditions place on healthcare systems and economies, particularly in countries like Germany.
Prevalence and Economic Impact
The study, which examined 47 European countries, estimated the prevalence of several key sleep disorders in the adult population:
- Obstructive Sleep Apnea (OSA): 18%
- Insomnia: 10%
- Restless Legs Syndrome (RLS): 3%
- Narcolepsy: 0.03%
- REM Sleep Behavior Disorder (RBD): 0.009%
The economic burden associated with these disorders is considerable. In Germany alone, the annual costs linked to OSA, chronic insomnia, RLS, narcolepsy, and RBD are estimated at €106 billion. This figure includes direct medical expenses and work-related absence costs for adults aged 20, and over.
Cost Breakdown by Disorder
Across Europe, OSA and insomnia are the most costly sleep disorders:
- Obstructive Sleep Apnea (OSA): €184 billion
- Insomnia: €158 billion
- Restless Legs Syndrome (RLS): €79 billion
- Narcolepsy: €905 million
- REM Sleep Behavior Disorder (RBD): €436 million
Direct and indirect costs account for 48% and 52% of these expenses, respectively. Data on informal care costs are currently unavailable.
Germany’s Position in Europe
In a comparison of 30 high-income countries, Germany ranks fourth with per capita costs exceeding €1,200 per year for sleep disorders. The actual economic burden in Germany is likely higher, as the study’s calculations do not fully account for factors such as presenteeism (reduced productivity while at work), subclinical sleep disorders, sleep disorders in minors, and long-term indirect costs.
The Need for Prioritized Sleep Health
Researchers emphasize the need to prioritize sleep health as a public health concern to mitigate the significant health and economic consequences of sleep disorders. France has already initiated measures to address this issue. The French Ministry of Health has launched a roadmap for improving sleep quality.
“Our modeling study sheds light on the economic implications of sleep disorders in Germany and other European countries. In order to cushion the health and economic consequences, awareness of the importance of sleep health should be raised and prevention, diagnostics and care should be improved. In order to be able to act in an evidence-based manner in the future, research in this area should also be promoted,” says Luisa Welter from the University of Duisburg-Essen, a German co-author of the study.
Looking Ahead
The unexpectedly high prevalence and substantial economic burden associated with sleep disorders underscore the need for increased awareness, improved prevention, diagnostics, and care. Further research is crucial to fully understand the impact of sleep disorders and develop effective strategies to address this growing public health challenge.